Document is current
Any future updates will be listed below
-
Authors
West, Phillip K.
McCorkindale, Andrew N.
Guennewig, Boris
Ashhurst, Thomas M.
Viengkhou, Barney
Hayashida, Emina
Jung, So Ri
Butovsky, Oleg
Campbell, Iain L.
Hofer, Markus J. http://orcid.org/0000-0001-5111-3978
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council Australia (RG180378)
BrightFocus Foundation (2020A016806)
National Institute of Neurological Disorders and Stroke (R01 NS088137)
National Institute on Aging (R01 AG051812, R01 AG054672)
National Eye Institute (R01 EY027921)
Australian Government (Research Training Program scholarship)
- License Information
-
More Information
Article History
Received: 11 November 2021
Accepted: 24 March 2022
First Online: 16 April 2022
Declarations
:
: All animal experiments were performed in compliance with the NSW Animal Research Act and its associated regulations and the 2013 NHMRC Australian code for the care and use of animals for scientific purposes. Ethical approval for the use of all mice was obtained from the animal ethics committee of the University of Sydney (2014/699, 2015/758 and 2018/1428).
: Not applicable.
: B.G. is a director of Pacific Analytics PTY LTD & SMRTR PTY LTD, Australia, which had no role in the design, execution, analysis or preparation of the manuscript. O.B. has collaborations with Sanofi, GSK, Regulus Therapeutics; research funding from Sanofi, GSK, miRagen Therapeutics, honoraria for lectures, consultancy: Camp4. The other authors declare no other competing interests.
